Yes but CEs also need to have a valid 340B purchase of one of the company’s covered outpatient drugs from the contract pharmacy during the first 3 quarters of 2020. If no purchases in the first 3 quarters of 2020 then no 340B pricing is offered even if the CE shares the data through 340B ESP.
No
Yes
All Products except Adcirca
All covered entity types (no exceptions)